chitosan has been researched along with Meningitis, Meningococcal, Serogroup A in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baudner, BC; Costantino, P; Del Giudice, G; Giuliani, MM; Junginger, HE; Morandi, M; Rappuoli, R; Verhoef, JC | 1 |
Borrow, R; Cosgrove, C; Giemza, R; Griffin, GE; Heath, PT; Huo, Z; Lewis, DJ; McNeela, EA; Mills, KH; Rappuoli, R; Sinha, R | 1 |
1 trial(s) available for chitosan and Meningitis, Meningococcal, Serogroup A
Article | Year |
---|---|
Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with
Topics: Adult; Antibodies, Bacterial; Chitosan; Diphtheria; Diphtheria Toxin; Female; Humans; Immune Sera; Immunoglobulin A; Immunoglobulin G; Insufflation; Male; Meningitis, Meningococcal; Meningococcal Vaccines; Nasal Lavage Fluid; Nasal Mucosa; Serum Bactericidal Test; Vaccines, Conjugate | 2005 |
1 other study(ies) available for chitosan and Meningitis, Meningococcal, Serogroup A
Article | Year |
---|---|
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Chitin; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Meningitis, Meningococcal; Meningococcal Vaccines; Mice; Mice, Inbred BALB C; Neisseria meningitidis, Serogroup C | 2004 |